Despite short supply, COVAX distributed nearly 40 mn vaccine doses: WHO

Close to 40 million Covid-19 vaccine doses have already been distributed through the COVAX Facility, but vaccine supplies are still stalled due to tremendous demand especially in India, the WHO said

Covax
IANS Geneva
2 min read Last Updated : Apr 13 2021 | 8:14 AM IST

Close to 40 million Covid-19 vaccine doses have already been distributed through the COVAX Facility, half of them in Africa, but vaccine supplies are still stalled due to "tremendous demand" especially in India, the World Health Organization (WHO) said.

COVAX, a WHO-led program to secure equitable access to vaccines for low and middle-income countries, "has, as of today, distributed just over 38.7 million doses and we expect to get past 40 million doses later this week," Bruce Aylward, the WHO's senior advisor to the director general on organisational change, said at a press conference on Monday, Xinhua news agency reported.

"Over 40 countries on the African continent will have received doses by the end of this week, and they will receive nearly half of the doses from COVAX," he added.

However, the COVAX Facility has experienced major difficulties in accessing vaccines, especially since the Serum Institute of India, "one of the main producers that supply the COVAX Facility" according to Aylward, cut back on AstraZeneca vaccine deliveries due to the "tremendous demand" created by the "escalating outbreak in India."

One solution suggested by the WHO to ensure proper immunization is to administer the second AstraZeneca dose after "12 weeks" or even a bit later, Aylward said.

At the same time, the WHO urged populations to continue practicing the infection control measures as vaccines represent just one approach to dealing with Covid-19.

"There was a nine per cent increase in transmissions last week, the seventh consecutive week when we've seen an increase in transmission, and a five percent increase in the number of deaths," said Maria Van Kerkhove, the WHO's technical lead on Covid-19.

"We are at a critical point of the pandemic right now," she stressed.

--IANS

int/

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus VaccineCoronavirus TestsWHO

First Published: Apr 13 2021 | 8:12 AM IST

Next Story